Literature DB >> 2180711

The epidemiology of enterococci.

C Chenoweth1, D Schaberg.   

Abstract

The enterococci are emerging as a significant cause of nosocomial infections, accounting for approximately 10% of hospital acquired infections. They are found as normal inhabitants of the human gastrointestinal tract, but may also colonize the oropharynx, vagina, perineal region and soft tissue wounds of asymptomatic patients. Until recently, evidence indicated that most enterococcal infections arose from patients' own endogenous flora. Recent studies, however, suggest that exogenous acquisition may occur and that person-to-person spread, probably on the hands of medical personnel, may be a significant mode of transmission of resistant enterococci within the hospital. The use of broad-spectrum antibiotics, especially cephalosporins, is another major factor in the increasing incidence of enterococcal infections. These findings suggest that barrier precautions, as applied with other resistant nosocomial pathogens, along with more judicial use of antibiotics may be beneficial in preventing nosocomial spread of resistant enterococci.

Entities:  

Mesh:

Year:  1990        PMID: 2180711     DOI: 10.1007/BF01963631

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  90 in total

1.  Identification of Enterococcus species isolated from human infections by a conventional test scheme.

Authors:  R R Facklam; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

2.  Antimicrobial susceptibility of group D hemolytic streptococci (enterococci).

Authors:  H J Simon
Journal:  Am J Med Sci       Date:  1967-01       Impact factor: 2.378

3.  Rapid identification of enterococci.

Authors:  G S Bosley; R R Facklam; D Grossman
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

4.  A pure enterococcal abscess after cesarean section.

Authors:  R S Gibbs; H M Listwa; R B Dreskin
Journal:  J Reprod Med       Date:  1977-07       Impact factor: 0.142

5.  Bacteria and aetiology of cancer of large bowel.

Authors:  M J Hill; B S Drasar; G Hawksworth; V Aries; J S Crowther; R E Williams
Journal:  Lancet       Date:  1971-01-16       Impact factor: 79.321

6.  Enigmatic enterococcal endocarditis.

Authors:  W M Scheld; G L Mandell
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

7.  Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.

Authors:  P Toala; A McDonald; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1969-12       Impact factor: 2.378

8.  Effect of protein binding on the activity of penicillins in combination with gentamicin against enterococci.

Authors:  R H Glew; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

9.  Nosocomial urinary tract infections due to enterococcus. Ten years' experience at a university hospital.

Authors:  A J Morrison; R P Wenzel
Journal:  Arch Intern Med       Date:  1986-08

10.  Enterococcal bacteremia in surgical patients.

Authors:  D T Barrall; P R Kenney; G J Slotman; K W Burchard
Journal:  Arch Surg       Date:  1985-01
View more
  29 in total

1.  Survival of Enterococcus faecalis in mouse peritoneal macrophages.

Authors:  C R Gentry-Weeks; R Karkhoff-Schweizer; A Pikis; M Estay; J M Keith
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Rethinking indicators of microbial drinking water quality for health studies in tropical developing countries: case study in northern coastal Ecuador.

Authors:  Karen Levy; Kara L Nelson; Alan Hubbard; Joseph N S Eisenberg
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

3.  The ponA gene of Enterococcus faecalis JH2-2 codes for a low-affinity class A penicillin-binding protein.

Authors:  Colette Duez; Séverine Hallut; Noureddine Rhazi; Séverine Hubert; Ana Amoroso; Fabrice Bouillenne; André Piette; Jacques Coyette
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

4.  Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin.

Authors:  W W Niu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

5.  Importance of the E-46-D-160 polypeptide segment of the non-penicillin-binding module for the folding of the low-affinity, multimodular class B penicillin-binding protein 5 of Enterococus hirae.

Authors:  M E Mollerach; P Partoune; J Coyette; J M Ghuysen
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

6.  Surveillance of infections in hospital: agents and antibiotic-resistance.

Authors:  F Riccardi; A Noce; S Falco; P Giudiceandrea; L Palombi; A Panà
Journal:  Eur J Epidemiol       Date:  1997-02       Impact factor: 8.082

7.  Infection of central nervous system by motile Enterococcus: first case report.

Authors:  A Kurup; W S Tee; L H Loo; R Lin
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 8.  Antimicrobial resistance in Canada.

Authors:  John Conly
Journal:  CMAJ       Date:  2002-10-15       Impact factor: 8.262

9.  Genome sequence of Enterococcus faecium clinical isolate LCT-EF128.

Authors:  Zhenhong Chen; De Chang; Yuanqiang Zou; Longxiang Su; Yuanfang Zhu; Xiangqun Fang; Junfeng Wang; Yinghua Guo; Jiao Zhao; Dongfang Li; Chengxiang Fang; Ruifu Yang; Changting Liu
Journal:  J Bacteriol       Date:  2012-09       Impact factor: 3.490

10.  In vitro activity of the new glycopeptide decaplanin.

Authors:  H C Neu; N X Chin; W W Niu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.